-
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease
Mato Prado, M., Puik, J. R., Castellano, L., López-Jiménez, E., Liu, D. S. K., Meijer, L. L., Le Large, T. Y. S., Rees, E., Funel, N., Sivakumar, S., Pereira, S. P., Kazemier, G., Zonderhuis, B. M., Erdmann, J. I., Swijnenburg, R-J., Frilling, A., Jiao, L. R., Stebbing, J., Giovannetti, E., Krell, J., & 1 others , 1 Dec 2023, In: Experimental hematology & oncology. 12, 1, p. 101Research output: Contribution to journal › Article › Academic › peer-review
-
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease
Mato Prado, M., Puik, J. R., Castellano, L., López-Jiménez, E., Liu, D. S. K., Meijer, L. L., le Large, T. Y. S., Rees, E., Funel, N., Sivakumar, S., Pereira, S. P., Kazemier, G., Zonderhuis, B. M., Erdmann, J. I., Swijnenburg, R-J., Frilling, A., Jiao, L. R., Stebbing, J., Giovannetti, E., Krell, J., & 1 others , 1 Dec 2023, In: Experimental hematology & oncology. 12, 1, 101.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
hENT1 as a Predictive Biomarker in PDAC—Letter
Boyd, L. N. C., Ali, M., Puik, J. R., Meijer, L. L., le Large, T. Y. S., van Laarhoven, H. W. M., Giovannetti, E. & Kazemier, G., 1 Aug 2023, In: Clinical Cancer Research. 29, 15, p. 2944 1 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications